2025 - PR Telemedicine Technologies and Micron Join Forces Under the CRO Alliance 2024 - PR TTelemedicine Technologies & Artialis partner for clinical research innovation - PR Telemedicine Technologies wins BSMA Clinical Trials Supply Chain Award for groundbreaking CleanWeb™-RTSM module - PR Revenues 2023 2023 - PR VisionHM listed at UGAP - PR acquisition of the French start-up CTMA - PR FY2023 Q1 results - PR FY2023 Q2 results - PR TTSA joins 40-Partner Consortium in xShare Initiative 2022 - PR acquisition of the Swiss company DAPSYS - PR BSA AIR - PR new facilities in Laval, France - PR new facilities in Liège, Belgium - PR FY2022 results 2021 - PR acquisition of the Belgian eCRO Lambda-Plus - PR VisionHM listed at UniHA
Contact
Investors relation
Telemedicine Technologies is the publisher of e-Health solutions, market leader in the field of Clinical Research with its CleanWeb™ solution, a secure Internet platform dedicated to the electronic management of clinical trials and registries.
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
June 26, 2025
June 30 – 4:00 PM to 5:15 PM (CET) xShare, an EU-funded project, strengthens procurement capabilities in digital health by translating the European Electronic Health Record Exchange Format (EEHRxF) into concrete requirements for tenders. This inaugural webinar presents key EU rules and promotes the procurement of interoperable solutions. It aims to raise awareness, share innovative […]
June 26, 2025
June 25–27 – JETRO – Japan External Trade Organization Pavilion – Osaka Booth Hall 6‑A, A‑0408 Philippe Haran – MD, is representing Telemedicine Technologies at the Japan Health Exhibition 2025, as a guest of Micron, Inc., a valued member of our CROAlliance partner. At Micron’s booth, he’s engaging with healthcare leaders and exploring collaboration opportunities […]
June 26, 2025
Applied Clinical Trials Online At a time when artificial intelligence (AI) is redefining industries at an unprecedented pace, the pharmaceutical sector stands on the brink of a progressive transformation. AI is not just a tool but a catalyst that promises to accelerate drug development timelines in ways we’ve never seen before. However, the true potential […]